Our APIs, such as acetaminophen and salicylamide included in antipyretics, analgesics, and anti-inflammatory agents that are the base compounds of commercially available cold preparations, are positioned as products with a top market share in Japan.
Other products, including vasoconstrictors, vasodilators, antitussive and expectorant agents, antiallergic agents, and antibacterial, are widely sold to pharmaceutical companies.
Above all, we are the only manufacturer of phenylephrine hydrochloride in Japan, and have considerable market share around the world.
We were also the first in the world to succeed in the industrial manufacturing of the plant-extracted natural drug pilocarpine hydrochloride (glaucoma medication, drugs for xerostomia) by total synthesis.
In addition, we are the only manufacturer of calcium glycerophosphate calcium preparation, and it is used in a wide range of products from pharmaceuticals to food additives.
Thanks to high praise and trust in our advanced technologies, we engage in custom manufacturing in response to outsourcing by many large pharmaceutical manufacturers both in and outside Japan.
We continue to perfect our technology and increase trust, and thereby aim to become a global API manufacturer based on manufacturing control and quality control systems that have passed FDA inspections.
With our high technology of precious chemical synthesis backed by manufacturing results of APIs, our fine chemical product lines have widened into the field of organic synthesis technologies.
We have started development of photographic chemical intermediates of pyrazolone compounds, and their applications in products seem to have unlimited expansion, such as liquid crystal intermediates, OLED intermediates, and more.